Drug-Eluting Bioabsorbable Stents Market Report

RA01225

Drug-Eluting Bioabsorbable Stents Market, by Type (Serolimus and Paclitaxel Drug-Eluting Stents, Sirolimus Drug Eluting Stents), Application (Coronary Artery Diseases, Peripheral Artery Diseases): Global Opportunity Analysis and Industry Forecast, 2020-2027

RA01225

Pages: 140

Jan 2023

The global drug-eluting bioabsorbable stents market is estimated to surpass $807.0 million by 2027, exhibiting a CAGR of 3.4% from 2020 to 2027.

The report provides all-inclusive analysis of global drug-eluting bioabsorbable stents market with comprehensive study of the various facets of the market including market dynamics, major segments and regions, top leading players, and competitive landscape.

The report emphasizes current market scenario and future trends of the global drug-eluting bioabsorbable stents market which gleaned from the impact of various market dynamics such as drivers, challenges & restraints, lucrative opportunities. The report also highlights the key forces that are shaping the market. Besides, the report provides Porter’s five forces analysis which precisely underlines the impact of key forces on the global drug-eluting bioabsorbable stents market.

In addition, the report provides market size and forecast scrutinizing global drug-eluting bioabsorbable stents market through different segments. The report highlights the geographical market analysis of these segments and each segment is thoroughly studied at regional as well as country level to get clearer picture of the global drug-eluting bioabsorbable stents market. In the report, the global drug-eluting bioabsorbable stents market is divided into four major regions including North America, Europe, Asia-Pacific, and LAMEA. These regions are further divided into major countries to cover drug-eluting bioabsorbable stents market landscape in respective regions.

Furthermore, competitive scenario of the global drug-eluting bioabsorbable stents market is covered in the report. Major players functioning in the global drug-eluting bioabsorbable stents market are also studied to understand their position and competitive strengths in the industry. The major company profiles covered in the report include various company’s datum such as brief overview, recent financials, main executives, adoption of key growth strategies, novel advancements or initiatives to sustain and expand their position in the global drug-eluting bioabsorbable stents market, and others.

Research Methodology

Research Dive offers its clients extensive research and analysis gleaned from wide variety of factual inputs that largely includes interview with participants of the industry, reliable data & statistics, and regional intelligence. The in-house experts of the industry play a crucial role in designing analytic tools and models, tailor-made to the requests of an industry segment. The data and statistics are sterilized with these analytical tools and models, which enhances the accuracy of our advice and recommendations.

This research report is delivered by Research Dive by conducting long hours of discussions and interviews, with a broad range of stakeholders, which includes upstream and downstream participants. Our analysts have performed a mix of primary and secondary research for the market estimations and forecasts. A number of product type literatures, industry releases, annual reports, and other related documents of major participants of the industry have been reviewed, to better understand the global drug-eluting bioabsorbable stents market scenario. The initial phase of our in-depth study, where we perform wide-range data mining, referring to proficient & verified data sources such as independent studies, medical journals, technical journals, releases by trade association, materials published by government & regulatory authorities, and other.

KEY MARKET BENEFITS

This report is a compilation of detailed study, information, valid inputs from industry experts & industry participants across the value chain, and quantitative & qualitative assessment by analysts of the industry.

The report provides a comprehensive analysis along with the current trends of market during the forecast period from 2019 to 2027 to identify & comprehend the prevailing opportunities and the strategic assessment of the global drug-eluting bioabsorbable stents market growth.

The report studies the market from 2019 to 2027 and maps the qualitative impact of several industry factors on market segments as well as geographies.

The report provides market estimations and size which is based on in-depth analysis of recent & key developments in the drug-eluting bioabsorbable stents market.

The development strategies implemented by the key industry players are conscripted in the report to understand the competitive scenario of the global drug-eluting bioabsorbable stents market.

KEY MARKET SEGMENTS

The market has been studied based on the following segments:

Type: Serolimus and Paclitaxel Drug-Eluting Stents, Sirolimus Drug Eluting Stents

Application: Coronary Artery Diseases, Peripheral Artery Diseases

Region:

The global drug-eluting bioabsorbable stents market is divided into North America, Europe, Asia Pacific, and LAMEA.

The above-mentioned regions are further dived in countries as follows:

North America
- U.S.
- Canada
- Mexico

Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe

Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific

LAMEA
- Brazil
- Argentina
- Saudi Arabia
- South Africa
- UAE
- Rest of LAMEA

KEY MARKET PLAYERS

The report covers the major players operating in the global drug-eluting bioabsorbable stents market that focus on advancements & innovations and geographical expansion of product portfolios to obtain a competitive edge in the market space. The major players enlisted in the report include Elixir Medical Corporation, Biosensors International, Innovative Health Technologies, MicroPort Scientific Corporation, …., and others.

The report summarizes various aspects of all these key players that include as follows:

1. Medtronic

2. B.Braun Melsungen

3. Abbott Laboratories

4. Boston Scientific Corporation

5. Biosensors International

6. Terumo Corporation

7. MicroPort Scientific Corporation

8. Alvimedica

9. Biotronik

10. Elixir Medical Corporation

11. Innovative Health Technologies

1. RESEARCH METHODOLOGY
- 1.1. Desk Research
- 1.2. Real time insights and validation
- 1.3. Forecast model
- 1.4. Assumptions and forecast parameters
- 1.5. Market size estimation
  - 1.5.1. Top-down approach
  - 1.5.2. Bottom-up approach
2. REPORT SCOPE
- 2.1. Market definition
- 2.2. Key objectives of the study
- 2.3. Report overview
- 2.4. Market segmentation
- 2.5. Overview of the impact of COVID-19 on Global Drug-Eluting Bioabsorbable Stents Market
3. EXECUTIVE SUMMARY
4. MARKET OVERVIEW
- 4.1. Introduction
- 4.2. Growth impact forces
  - 4.2.1. Drivers
  - 4.2.2. Restraints
  - 4.2.3. Opportunities
- 4.3. Market value chain analysis
  - 4.3.1. List of raw material suppliers
  - 4.3.2. List of manufacturers
  - 4.3.3. List of distributors
- 4.4. Innovation & sustainability matrices
  - 4.4.1. Technology matrix
  - 4.4.2. Regulatory matrix
- 4.5. Porter’s five forces analysis
  - 4.5.1. Bargaining power of suppliers
  - 4.5.2. Bargaining power of consumers
  - 4.5.3. Threat of substitutes
  - 4.5.4. Threat of new entrants
  - 4.5.5. Competitive rivalry intensity
- 4.6. PESTLE analysis
  - 4.6.1. Political
  - 4.6.2. Economical
  - 4.6.3. Social
  - 4.6.4. Technological
  - 4.6.5. Environmental
- 4.7. Impact of COVID-19 on Drug-Eluting Bioabsorbable Stents Market
  - 4.7.1. Pre-covid market scenario
  - 4.7.2. Post-covid market scenario
5. Drug-Eluting Bioabsorbable Stents Market, By Infections
- 5.1. Overview
- 5.2 Serolimus and Paclitaxel Drug-Eluting Stents
  - 5.2.1 Definition, key trends, growth factors, and opportunities
  - 5.2.2 Market size analysis, by region, 2020-2027
  - 5.2.3 Market share analysis, by country, 2020-2027
- 5.3 Sirolimus Drug Eluting Stents
  - 5.3.1 Definition, key trends, growth factors, and opportunities
  - 5.3.2 Market size analysis, by region, 2020-2027
  - 5.3.3 Market share analysis, by country, 2020-2027
- 5.4 Research Dive Exclusive Insights
  - 5.4.1 Market attractiveness
  - 5.4.2 Competition heatmap
6. Drug-Eluting Bioabsorbable Stents Market, By Resorbability
- 6.1. Overview
- 6.2 Coronary Artery Diseases
  - 6.2.1 Definition, key trends, growth factors, and opportunities
  - 6.2.2 Market size analysis, by region, 2020-2027
  - 6.2.3 Market share analysis, by country, 2020-2027
- 6.3 Peripheral Artery Diseases
  - 6.3.1 Definition, key trends, growth factors, and opportunities
  - 6.3.2 Market size analysis, by region, 2020-2027
  - 6.3.3 Market share analysis, by country, 2020-2027
- 6.4 Research Dive Exclusive Insights
  - 6.4.1 Market attractiveness
  - 6.4.2 Competition heatmap
7. Drug-Eluting Bioabsorbable Stents Market, By Region
- 7.1 North America
  - 7.1.1 U.S
    - 7.1.1.1 Market size analysis, By Infections, 2020-2027
    - 7.1.1.2 Market size analysis, By Resorbability, 2020-2027
  - 7.1.2 Canada
    - 7.1.2.1 Market size analysis, By Infections, 2020-2027
    - 7.1.2.2 Market size analysis, By Resorbability, 2020-2027
  - 7.1.3 Mexico
    - 7.1.3.1 Market size analysis, By Infections, 2020-2027
    - 7.1.3.2 Market size analysis, By Resorbability, 2020-2027
  - 7.1.4 Research Dive Exclusive Insights
    - 7.1.4.1 Market attractiveness
    - 7.1.4.2 Competition heatmap
- 7.2 Europe
  - 7.2.1 Germany
    - 7.2.1.1 Market size analysis, By Infections, 2020-2027
    - 7.2.1.2 Market size analysis, By Resorbability, 2020-2027
  - 7.2.2 UK
    - 7.2.2.1 Market size analysis, By Infections, 2020-2027
    - 7.2.2.2 Market size analysis, By Resorbability, 2020-2027
  - 7.2.3 France
    - 7.2.3.1 Market size analysis, By Infections, 2020-2027
    - 7.2.3.2 Market size analysis, By Resorbability, 2020-2027
  - 7.2.4 Spain
    - 7.2.4.1 Market size analysis, By Infections, 2020-2027
    - 7.2.4.2 Market size analysis, By Resorbability, 2020-2027
  - 7.2.5 Italy
    - 7.2.5.1 Market size analysis, By Infections, 2020-2027
    - 7.2.5.2 Market size analysis, By Resorbability, 2020-2027
  - 7.2.6 Rest of Europe
    - 7.2.6.1 Market size analysis, By Infections, 2020-2027
    - 7.2.6.2 Market size analysis, By Resorbability, 2020-2027
  - 7.2.7 Research Dive Exclusive Insights
    - 7.2.7.1 Market attractiveness
    - 7.2.7.2 Competition heatmap
- 7.3 Asia-Pacific
  - 7.3.1 China
    - 7.3.1.1 Market size analysis, By Infections, 2020-2027
    - 7.3.1.2 Market size analysis, By Resorbability, 2020-2027
  - 7.3.2 Japan
    - 7.3.2.1 Market size analysis, By Infections, 2020-2027
    - 7.3.2.2 Market size analysis, By Resorbability, 2020-2027
  - 7.3.3 India
    - 7.3.3.1 Market size analysis, By Infections, 2020-2027
    - 7.3.3.2 Market size analysis, By Resorbability, 2020-2027
  - 7.3.4 Australia
    - 7.3.4.1 Market size analysis, By Infections, 2020-2027
    - 7.3.4.2 Market size analysis, By Resorbability, 2020-2027
  - 7.3.5 South Korea
    - 7.3.5.1 Market size analysis, By Infections, 2020-2027
    - 7.3.5.2 Market size analysis, By Resorbability, 2020-2027
  - 7.3.6 Rest of Asia-Pacific
    - 7.3.6.1 Market size analysis, By Infections, 2020-2027
    - 7.3.6.2 Market size analysis, By Resorbability, 2020-2027
  - 7.3.7 Research Dive Exclusive Insights
    - 7.3.7.1 Market attractiveness
    - 7.3.7.2 Competition heatmap
- 7.4 LAMEA
  - 7.4.1 Brazil
    - 7.4.1.1 Market size analysis, By Infections, 2020-2027
    - 7.4.1.2 Market size analysis, By Resorbability, 2020-2027
  - 7.4.2 Saudi Arabia
    - 7.4.2.1 Market size analysis, By Infections, 2020-2027
    - 7.4.2.2 Market size analysis, By Resorbability, 2020-2027
  - 7.4.3 UAE
    - 7.4.3.1 Market size analysis, By Infections, 2020-2027
    - 7.4.3.2 Market size analysis, By Resorbability, 2020-2027
  - 7.4.4 South Africa
    - 7.4.4.1 Market size analysis, By Infections, 2020-2027
    - 7.4.4.2 Market size analysis, By Resorbability, 2020-2027
  - 7.4.5 Rest of LAMEA
    - 7.4.5.1 Market size analysis, By Infections, 2020-2027
    - 7.4.5.2 Market size analysis, By Resorbability, 2020-2027
  - 7.4.6 Research Dive Exclusive Insights
    - 7.4.6.1 Market attractiveness
    - 7.4.6.2 Competition heatmap
8. Competitive Landscape
- 8.1 Top winning strategies, 2020-2027
  - 8.1.1 By strategy
  - 8.1.2 By year
- 8.2 Strategic overview
- 8.3 Market share analysis, 2020-2027
9. Company Profiles
- 9.1 Medtronic
  - 9.1.1 Overview
  - 9.1.2 Business segments
  - 9.1.3 Product portfolio
  - 9.1.4 Financial performance
  - 9.1.5 Recent developments
  - 9.1.6 SWOT analysis
- 9.2 B.Braun Melsungen
  - 9.2.1 Overview
  - 9.2.2 Business segments
  - 9.2.3 Product portfolio
  - 9.2.4 Financial performance
  - 9.2.5 Recent developments
  - 9.2.6 SWOT analysis
- 9.3 Abbott Laboratories
  - 9.3.1 Overview
  - 9.3.2 Business segments
  - 9.3.3 Product portfolio
  - 9.3.4 Financial performance
  - 9.3.5 Recent developments
  - 9.3.6 SWOT analysis
- 9.4 Boston Scientific Corporation
  - 9.4.1 Overview
  - 9.4.2 Business segments
  - 9.4.3 Product portfolio
  - 9.4.4 Financial performance
  - 9.4.5 Recent developments
  - 9.4.6 SWOT analysis
- 9.5 Biosensors International
  - 9.5.1 Overview
  - 9.5.2 Business segments
  - 9.5.3 Product portfolio
  - 9.5.4 Financial performance
  - 9.5.5 Recent developments
  - 9.5.6 SWOT analysis
- 9.6 Terumo Corporation
  - 9.6.1 Overview
  - 9.6.2 Business segments
  - 9.6.3 Product portfolio
  - 9.6.4 Financial performance
  - 9.6.5 Recent developments
  - 9.6.6 SWOT analysis
- 9.7 MicroPort Scientific Corporation
  - 9.7.1 Overview
  - 9.7.2 Business segments
  - 9.7.3 Product portfolio
  - 9.7.4 Financial performance
  - 9.7.5 Recent developments
  - 9.7.6 SWOT analysis
- 9.8 Alvimedica
  - 9.8.1 Overview
  - 9.8.2 Business segments
  - 9.8.3 Product portfolio
  - 9.8.4 Financial performance
  - 9.8.5 Recent developments
  - 9.8.6 SWOT analysis
- 9.9 Biotronik
  - 9.9.1 Overview
  - 9.9.2 Business segments
  - 9.9.3 Product portfolio
  - 9.9.4 Financial performance
  - 9.9.5 Recent developments
  - 9.9.6 SWOT analysis
- 9.10 Elixir Medical Corporation
  - 9.10.1 Overview
  - 9.10.2 Business segments
  - 9.10.3 Product portfolio
  - 9.10.4 Financial performance
  - 9.10.5 Recent developments
  - 9.10.6 SWOT analysis
- 9.11 Innovative Health Technologies
  - 9.11.1 Overview
  - 9.11.2 Business segments
  - 9.11.3 Product portfolio
  - 9.11.4 Financial performance
  - 9.11.5 Recent developments
  - 9.11.6 SWOT analysis

Purchase Options

Individual License $4290 Corporate License $4920

Personalize this research

Triangulate with your own data
Request your format and definition
Get a deeper dive on a specific application, geography, customer or competitor

10% Off on Customization

Speak To The Analyst
Or Schedule A Call

+ 1-888-961-4454 Toll - Free
support@researchdive.com

Drug-Eluting Bioabsorbable Stents Market Report

Drug-Eluting Bioabsorbable Stents Market, by Type (Serolimus and Paclitaxel Drug-Eluting Stents, Sirolimus Drug Eluting Stents), Application (Coronary Artery Diseases, Peripheral Artery Diseases): Global Opportunity Analysis and Industry Forecast, 2020-2027

1. RESEARCH METHODOLOGY

1.1. Desk Research

1.2. Real time insights and validation

1.3. Forecast model

1.4. Assumptions and forecast parameters

1.5. Market size estimation

1.5.1. Top-down approach

1.5.2. Bottom-up approach

2. REPORT SCOPE

2.1. Market definition

2.2. Key objectives of the study

2.3. Report overview

2.4. Market segmentation

2.5. Overview of the impact of COVID-19 on Global Drug-Eluting Bioabsorbable Stents Market

3. EXECUTIVE SUMMARY

4. MARKET OVERVIEW

4.1. Introduction

4.2. Growth impact forces

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Opportunities

4.3. Market value chain analysis

4.3.1. List of raw material suppliers

4.3.2. List of manufacturers

4.3.3. List of distributors

4.4. Innovation & sustainability matrices

4.4.1. Technology matrix

4.4.2. Regulatory matrix

4.5. Porter’s five forces analysis

4.5.1. Bargaining power of suppliers

4.5.2. Bargaining power of consumers

4.5.3. Threat of substitutes

4.5.4. Threat of new entrants

4.5.5. Competitive rivalry intensity

4.6. PESTLE analysis

4.6.1. Political

4.6.2. Economical

4.6.3. Social

4.6.4. Technological

4.6.5. Environmental

4.7. Impact of COVID-19 on Drug-Eluting Bioabsorbable Stents Market

4.7.1. Pre-covid market scenario

4.7.2. Post-covid market scenario

5. Drug-Eluting Bioabsorbable Stents Market, By Infections

5.1. Overview

5.2 Serolimus and Paclitaxel Drug-Eluting Stents

5.2.1 Definition, key trends, growth factors, and opportunities

5.2.2 Market size analysis, by region, 2020-2027

5.2.3 Market share analysis, by country, 2020-2027

5.3 Sirolimus Drug Eluting Stents

5.3.1 Definition, key trends, growth factors, and opportunities

5.3.2 Market size analysis, by region, 2020-2027

5.3.3 Market share analysis, by country, 2020-2027

5.4 Research Dive Exclusive Insights

5.4.1 Market attractiveness

5.4.2 Competition heatmap

6. Drug-Eluting Bioabsorbable Stents Market, By Resorbability

6.1. Overview

6.2 Coronary Artery Diseases

6.2.1 Definition, key trends, growth factors, and opportunities

6.2.2 Market size analysis, by region, 2020-2027

6.2.3 Market share analysis, by country, 2020-2027

6.3 Peripheral Artery Diseases

6.3.1 Definition, key trends, growth factors, and opportunities

6.3.2 Market size analysis, by region, 2020-2027

6.3.3 Market share analysis, by country, 2020-2027

6.4 Research Dive Exclusive Insights

6.4.1 Market attractiveness

6.4.2 Competition heatmap

7. Drug-Eluting Bioabsorbable Stents Market, By Region

7.1 North America

7.1.1 U.S

7.1.1.1 Market size analysis, By Infections, 2020-2027

7.1.1.2 Market size analysis, By Resorbability, 2020-2027

7.1.2 Canada

7.1.2.1 Market size analysis, By Infections, 2020-2027

7.1.2.2 Market size analysis, By Resorbability, 2020-2027

7.1.3 Mexico